Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Amylin Pharmaceuticals, LLC.)"
Count: 41
Selected: 0
NCT IDTitle
NCT01137695Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
NCT01588418Acute Effect of Exenatide on Brain Glucose Metabolism
NCT01501084Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
NCT01381926Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
NCT01165944Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus
NCT01154933Exeantide in Type 2 Diabetes on Insulin
NCT01061775Effects of Exenatide on Hypothalamic Obesity
NCT01006889Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
NCT00876213Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans
NCT00845559The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
NCT00842075Pramlintide in Adolescents With Type 1 Diabetes
NCT00806520Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
NCT00803920Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
NCT00790699Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port
NCT00736229Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
NCT00732147Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
NCT00690235Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
NCT00502138A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
NCT00461552Therapeutic Approaches to HAART-Induced Lipodystrophy
NCT00460304The Effect of Pramlintide on Meal Time Insulin Bolus
NCT00442767Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
NCT00344851Exenatide and Metformin Therapy in Overweight Women With PCOS
NCT01364584Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
NCT00882050Intravenous Exenatide (Byetta) During Surgery
NCT00855439Evaluation of Exenatide in Patients With Diabetic Neuropathy
NCT00667732How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
NCT00529204Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
NCT00456885The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
NCT00353834The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes
NCT01268644Effects of Metreleptin in Type 1 Diabetes Mellitus
NCT01181986The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
NCT00546728The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
NCT01147627Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
NCT01107717Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
NCT00710814Trial of Leptin Administration After Roux-en-Y Gastric Bypass
NCT00457938Novel Therapies for Metabolic Complications of Lipodystrophies
NCT02443922Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM
NCT02346344Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
NCT01663220Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
NCT01663207Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
NCT01454973Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects